The effectiveness of malaria camps as part of the Durgama Anchalare Malaria Nirakaran (DAMaN) program in Odisha, India: study protocol for a cluster-assigned quasi-experimental study

Global Health Action

Sanjib Mohanty¹  Timir K. Padhan¹  Mohammed A. Haque¹  Praveen K. Sahu¹  Catriona L.E.B Patterson²  Kevin K.A. Tetteh²  Anne Kessler³  Anna Maria Van Eijk³  Jane M. Carlton³  Steven A. Sullivan³  Danielle C. Ompad³  Yesim Tozan³  Madan M. Pradhan⁴  Joacim Rocklöv⁵ 

[1] Community Welfare Society Hospital;London School of Hygiene and Tropical Medicine;New York University;State Vector Borne Disease Control Programme;Umea University;

关键词: malaria camp;    malaria;    screening and treatment;    plasmodium;    malaria control program;    odisha;    daman;    cluster-assigned quasi-experimental study;   

DOI  :  10.1080/16549716.2021.1886458

来源: DOAJ

【 摘 要 】

The Indian state of Odisha has a longstanding battle with forest malaria. Many remote and rural villages have poor access to health care, a problem that is exacerbated during the rainy season when malaria transmission is at its peak. Approximately 62% of the rural population consists of tribal groups who are among the communities most negatively impacted by malaria. To address the persistently high rates of malaria in these remote regions, the Odisha State Malaria Control Program introduced ‘malaria camps’ in 2017 where teams of health workers visit villages to educate the population, enhance vector control methods, and perform village-wide screening and treatment. Malaria rates declined statewide, particularly in forested areas, following the introduction of the malaria camps, but the impact of the intervention is yet to be externally evaluated. This study protocol describes a cluster-assigned quasi-experimental stepped-wedge study with a pretest-posttest control group design that evaluates if malaria camps reduce the prevalence of malaria, compared to control villages which receive the usual malaria control interventions (e.g. IRS, ITNs), as detected by PCR.

【 授权许可】

Unknown